Exosens Stock: Approaching Peak Levels Following Better-than-Expected 2025 Results

Annual Financial Results Exceed Expectations

On Monday, Exosens revealed its annual accounts for 2025, reporting a consolidated revenue of 468.2 million euros, a 22.1% increase year over year. This performance, driven by the defense and night vision segments, surpassed the initial ambitions set by the management. The announcement immediately prompted adjustments from research firms. Deutsche Bank raised its price target from 52 to 55 euros, while maintaining a 'hold' recommendation. However, this new target is still below the current price, implying a potential downside of about 7.7%. On the other hand, BNP Paribas Exane was much more bullish, increasing its target from 49 to 64 euros, with an 'outperform' rating, suggesting a potential upside of approximately 7.4% compared to this morning's price. Both adjustments, dated February 25, reflect contrasting valuations of the group after these solid results.

Technical Outlook for Today's Session

Technically, today's session places Exosens at 59.60 euros, less than one euro away from the identified resistance at 60.50 euros. Breaking through this threshold could pave the way for further progression, as the stock has already gained 45.37% over three months and more than 142% over a year. The bullish trend is supported by the configuration of moving averages: the price is significantly above its 50-day moving average (53.24 euros) and its 200-day moving average (45.22 euros), confirming a well-established upward dynamic. The RSI, at 57, indicates that the stock is progressing without being in an overbought zone, theoretically leaving room before reaching a tension level that could hinder the movement. Regarding the financial calendar, the next key event is scheduled for April 27 with the release of the first quarter 2026 results, followed by the annual general meeting on May 22.